DISTINCT EFFECTS OF THE Β2-ADRENERGIC AGONIST FORMOTEROL AND THE CHOLINESTERASE INHIBITOR PYRIDOSTIGMINE IN A NEW MURINE MYASTHENIA MODEL WITH SPECIFIC VACHT DELETION IN MOTOR NEURONS

Bibliographic Details
Main Authors: Leonardo Rossi, Barbara Mota, Bruna Oliveira, Priscila Valadão, Matheus Magalhães-Gomes, Marco Prado, Vania Prado, Aline Miranda, Cristina Guatimosim
Format: Article
Language:English
Published: Elsevier 2023-10-01
Series:IBRO Neuroscience Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2667242123010199
_version_ 1797636345000099840
author Leonardo Rossi
Barbara Mota
Bruna Oliveira
Priscila Valadão
Matheus Magalhães-Gomes
Marco Prado
Vania Prado
Aline Miranda
Cristina Guatimosim
author_facet Leonardo Rossi
Barbara Mota
Bruna Oliveira
Priscila Valadão
Matheus Magalhães-Gomes
Marco Prado
Vania Prado
Aline Miranda
Cristina Guatimosim
author_sort Leonardo Rossi
collection DOAJ
first_indexed 2024-03-11T12:32:59Z
format Article
id doaj.art-cccd29eb2a764bdd9830932b625289e4
institution Directory Open Access Journal
issn 2667-2421
language English
last_indexed 2024-03-11T12:32:59Z
publishDate 2023-10-01
publisher Elsevier
record_format Article
series IBRO Neuroscience Reports
spelling doaj.art-cccd29eb2a764bdd9830932b625289e42023-11-06T04:24:31ZengElsevierIBRO Neuroscience Reports2667-24212023-10-0115S489S490DISTINCT EFFECTS OF THE Β2-ADRENERGIC AGONIST FORMOTEROL AND THE CHOLINESTERASE INHIBITOR PYRIDOSTIGMINE IN A NEW MURINE MYASTHENIA MODEL WITH SPECIFIC VACHT DELETION IN MOTOR NEURONSLeonardo Rossi0Barbara Mota1Bruna Oliveira2Priscila Valadão3Matheus Magalhães-Gomes4Marco Prado5Vania Prado6Aline Miranda7Cristina Guatimosim8Universidade Federal de Minas Gerais, Morphology, Belo Horizonte, BrazilUniversidade Federal de Minas Gerais, Morphology, Belo Horizonte, BrazilUniversidade Federal de Minas Gerais, Morphology, Belo Horizonte, BrazilUniversidade Federal de Minas Gerais, Morphology, Belo Horizonte, BrazilFaculdade de Ciências Médicas de Minas Gerais, Medicine, Belo Horizonte, BrazilRobarts Research Institute, Schulich School Of Medicine & Dentistry, London, CanadaRobarts Research Institute, Schulich School Of Medicine & Dentistry, London, CanadaUniversidade Federal de Minas Gerais, Morphology, Belo Horizonte, BrazilUniversidade Federal de Minas Gerais, Morphology, Belo Horizonte, Brazilhttp://www.sciencedirect.com/science/article/pii/S2667242123010199
spellingShingle Leonardo Rossi
Barbara Mota
Bruna Oliveira
Priscila Valadão
Matheus Magalhães-Gomes
Marco Prado
Vania Prado
Aline Miranda
Cristina Guatimosim
DISTINCT EFFECTS OF THE Β2-ADRENERGIC AGONIST FORMOTEROL AND THE CHOLINESTERASE INHIBITOR PYRIDOSTIGMINE IN A NEW MURINE MYASTHENIA MODEL WITH SPECIFIC VACHT DELETION IN MOTOR NEURONS
IBRO Neuroscience Reports
title DISTINCT EFFECTS OF THE Β2-ADRENERGIC AGONIST FORMOTEROL AND THE CHOLINESTERASE INHIBITOR PYRIDOSTIGMINE IN A NEW MURINE MYASTHENIA MODEL WITH SPECIFIC VACHT DELETION IN MOTOR NEURONS
title_full DISTINCT EFFECTS OF THE Β2-ADRENERGIC AGONIST FORMOTEROL AND THE CHOLINESTERASE INHIBITOR PYRIDOSTIGMINE IN A NEW MURINE MYASTHENIA MODEL WITH SPECIFIC VACHT DELETION IN MOTOR NEURONS
title_fullStr DISTINCT EFFECTS OF THE Β2-ADRENERGIC AGONIST FORMOTEROL AND THE CHOLINESTERASE INHIBITOR PYRIDOSTIGMINE IN A NEW MURINE MYASTHENIA MODEL WITH SPECIFIC VACHT DELETION IN MOTOR NEURONS
title_full_unstemmed DISTINCT EFFECTS OF THE Β2-ADRENERGIC AGONIST FORMOTEROL AND THE CHOLINESTERASE INHIBITOR PYRIDOSTIGMINE IN A NEW MURINE MYASTHENIA MODEL WITH SPECIFIC VACHT DELETION IN MOTOR NEURONS
title_short DISTINCT EFFECTS OF THE Β2-ADRENERGIC AGONIST FORMOTEROL AND THE CHOLINESTERASE INHIBITOR PYRIDOSTIGMINE IN A NEW MURINE MYASTHENIA MODEL WITH SPECIFIC VACHT DELETION IN MOTOR NEURONS
title_sort distinct effects of the β2 adrenergic agonist formoterol and the cholinesterase inhibitor pyridostigmine in a new murine myasthenia model with specific vacht deletion in motor neurons
url http://www.sciencedirect.com/science/article/pii/S2667242123010199
work_keys_str_mv AT leonardorossi distincteffectsoftheb2adrenergicagonistformoterolandthecholinesteraseinhibitorpyridostigmineinanewmurinemyastheniamodelwithspecificvachtdeletioninmotorneurons
AT barbaramota distincteffectsoftheb2adrenergicagonistformoterolandthecholinesteraseinhibitorpyridostigmineinanewmurinemyastheniamodelwithspecificvachtdeletioninmotorneurons
AT brunaoliveira distincteffectsoftheb2adrenergicagonistformoterolandthecholinesteraseinhibitorpyridostigmineinanewmurinemyastheniamodelwithspecificvachtdeletioninmotorneurons
AT priscilavaladao distincteffectsoftheb2adrenergicagonistformoterolandthecholinesteraseinhibitorpyridostigmineinanewmurinemyastheniamodelwithspecificvachtdeletioninmotorneurons
AT matheusmagalhaesgomes distincteffectsoftheb2adrenergicagonistformoterolandthecholinesteraseinhibitorpyridostigmineinanewmurinemyastheniamodelwithspecificvachtdeletioninmotorneurons
AT marcoprado distincteffectsoftheb2adrenergicagonistformoterolandthecholinesteraseinhibitorpyridostigmineinanewmurinemyastheniamodelwithspecificvachtdeletioninmotorneurons
AT vaniaprado distincteffectsoftheb2adrenergicagonistformoterolandthecholinesteraseinhibitorpyridostigmineinanewmurinemyastheniamodelwithspecificvachtdeletioninmotorneurons
AT alinemiranda distincteffectsoftheb2adrenergicagonistformoterolandthecholinesteraseinhibitorpyridostigmineinanewmurinemyastheniamodelwithspecificvachtdeletioninmotorneurons
AT cristinaguatimosim distincteffectsoftheb2adrenergicagonistformoterolandthecholinesteraseinhibitorpyridostigmineinanewmurinemyastheniamodelwithspecificvachtdeletioninmotorneurons